Cambridge Investment Research Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.37M | Sell |
52,726
-6,816
| -11% | -$565K | 0.01% | 932 |
|
2025
Q1 | $4.83M | Sell |
59,542
-5,860
| -9% | -$475K | 0.02% | 826 |
|
2024
Q4 | $5.89M | Sell |
65,402
-5,726
| -8% | -$516K | 0.02% | 714 |
|
2024
Q3 | $7.03M | Buy |
71,128
+2,250
| +3% | +$222K | 0.02% | 635 |
|
2024
Q2 | $6.39M | Sell |
68,878
-7,297
| -10% | -$677K | 0.02% | 642 |
|
2024
Q1 | $7.23M | Buy |
76,175
+10,176
| +15% | +$966K | 0.03% | 579 |
|
2023
Q4 | $5.89M | Sell |
65,999
-11,130
| -14% | -$994K | 0.03% | 623 |
|
2023
Q3 | $5.63M | Sell |
77,129
-34,096
| -31% | -$2.49M | 0.03% | 600 |
|
2023
Q2 | $9.25M | Buy |
111,225
+36,234
| +48% | +$3.01M | 0.04% | 407 |
|
2023
Q1 | $5.72M | Buy |
74,991
+6,872
| +10% | +$524K | 0.03% | 571 |
|
2022
Q4 | $5.65M | Sell |
68,119
-829
| -1% | -$68.8K | 0.03% | 555 |
|
2022
Q3 | $5.47M | Sell |
68,948
-125,447
| -65% | -$9.95M | 0.03% | 529 |
|
2022
Q2 | $14.4M | Buy |
194,395
+140,122
| +258% | +$10.4M | 0.08% | 248 |
|
2022
Q1 | $4.88M | Sell |
54,273
-15,238
| -22% | -$1.37M | 0.02% | 643 |
|
2021
Q4 | $7.78M | Buy |
69,511
+7,109
| +11% | +$796K | 0.03% | 472 |
|
2021
Q3 | $7.85M | Buy |
62,402
+128
| +0.2% | +$16.1K | 0.04% | 431 |
|
2021
Q2 | $8.43M | Sell |
62,274
-18,836
| -23% | -$2.55M | 0.04% | 423 |
|
2021
Q1 | $11M | Buy |
81,110
+5,681
| +8% | +$771K | 0.06% | 304 |
|
2020
Q4 | $10.6M | Buy |
75,429
+16,502
| +28% | +$2.32M | 0.06% | 291 |
|
2020
Q3 | $6.57M | Buy |
58,927
+3,664
| +7% | +$408K | 0.04% | 383 |
|
2020
Q2 | $6.19M | Buy |
55,263
+18,149
| +49% | +$2.03M | 0.05% | 377 |
|
2020
Q1 | $2.87M | Sell |
37,114
-11,029
| -23% | -$854K | 0.03% | 531 |
|
2019
Q4 | $4.58M | Buy |
48,143
+7,639
| +19% | +$727K | 0.04% | 499 |
|
2019
Q3 | $3.09M | Sell |
40,504
-861
| -2% | -$65.6K | 0.03% | 591 |
|
2019
Q2 | $3.63M | Buy |
41,365
+346
| +0.8% | +$30.3K | 0.03% | 513 |
|
2019
Q1 | $3.71M | Buy |
41,019
+2,083
| +5% | +$189K | 0.04% | 473 |
|
2018
Q4 | $2.79M | Sell |
38,936
-30,980
| -44% | -$2.22M | 0.03% | 520 |
|
2018
Q3 | $6.7M | Sell |
69,916
-13,919
| -17% | -$1.33M | 0.06% | 292 |
|
2018
Q2 | $7.98M | Buy |
83,835
+44,412
| +113% | +$4.23M | 0.08% | 233 |
|
2018
Q1 | $3.46M | Buy |
39,423
+13,718
| +53% | +$1.2M | 0.04% | 427 |
|
2017
Q4 | $2.18M | Sell |
25,705
-8,277
| -24% | -$703K | 0.03% | 556 |
|
2017
Q3 | $2.94M | Buy |
33,982
+7,796
| +30% | +$675K | 0.04% | 411 |
|
2017
Q2 | $2.02M | Buy |
26,186
+3,212
| +14% | +$248K | 0.03% | 514 |
|
2017
Q1 | $1.59M | Buy |
22,974
+724
| +3% | +$50.2K | 0.03% | 526 |
|
2016
Q4 | $1.32M | Buy |
22,250
+9,027
| +68% | +$534K | 0.02% | 564 |
|
2016
Q3 | $877K | Sell |
13,223
-223
| -2% | -$14.8K | 0.02% | 745 |
|
2016
Q2 | $727K | Buy |
13,446
+437
| +3% | +$23.6K | 0.02% | 757 |
|
2016
Q1 | $672K | Sell |
13,009
-532
| -4% | -$27.5K | 0.02% | 750 |
|
2015
Q4 | $951K | Buy |
13,541
+1,017
| +8% | +$71.4K | 0.02% | 565 |
|
2015
Q3 | $780K | Buy |
12,524
+3,195
| +34% | +$199K | 0.02% | 567 |
|
2015
Q2 | $2.35M | Sell |
9,329
-511
| -5% | -$129K | 0.07% | 283 |
|
2015
Q1 | $2.22M | Buy |
9,840
+1,737
| +21% | +$392K | 0.06% | 293 |
|
2014
Q4 | $1.51M | Buy |
8,103
+1,299
| +19% | +$242K | 0.05% | 361 |
|
2014
Q3 | $1.06M | Sell |
6,804
-139
| -2% | -$21.7K | 0.03% | 499 |
|
2014
Q2 | $1.07M | Sell |
6,943
-31,618
| -82% | -$4.87M | 0.04% | 440 |
|
2014
Q1 | $5.49M | Buy |
38,561
+23,427
| +155% | +$3.34M | 0.21% | 105 |
|
2013
Q4 | $1.97M | Buy |
15,134
+3,419
| +29% | +$445K | 0.08% | 240 |
|
2013
Q3 | $1.51M | Buy |
11,715
+2,259
| +24% | +$292K | 0.07% | 270 |
|
2013
Q2 | $986K | Buy |
+9,456
| New | +$986K | 0.05% | 324 |
|